The IHME projections were used by the Trump administration in developing national guidelines to mitigate the outbreak. Now, they are reportedly influencing White House thinking on how and when to "re-open" the country, STAT News reports.
China reported that its first quarter GDP contracted by 6.8% in 2020 from a year ago as the coronavirus outbreak seriously impacted the world's second largest economy.
Asian consumers are tightening their belts as they prepare for a coronavirus-induced hit to their finances. But growing confidence in China suggests there could be light at the end of the tunnel, according to a new study.
The partnership allows the Treasury to take advantage of the Fed's ability to swiftly inject money into the economy. It also effectively shifts debt off the Treasury's balance sheet and onto the Fed's.
The new guidance ramps up pressure on governors to loosen their restrictions, even as health experts and business leaders alike warn that widespread testing systems are needed before Americans can safely start returning to their normal lives.
Extending business interruption losses is a "self-inflicted injury" and would create "great uncertainty at a time when we have enough uncertainty," Chubb CEO Evan Greenberg told CNBC.
The company is also working on a fourth diagnostic test for the coronavirus: A "lateral flow" blood test that can provide a diagnosis even more quickly.
A Chicago hospital treating severe Covid-19 patients with Gilead Sciences' antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.
President Donald Trump is expected to roll out guidelines on how the U.S. can start to reopen for business in areas where coronavirus cases are on the decline and testing ramps up.
Some experts say America needs to perform 20 million to 30 million tests a day to begin getting the economy back to normal. One estimate says it will cost up to $500 billion over time for a program of widespread testing, contact tracings and data aggregation.